Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 8, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 8:15 a.m. PT (11:15 a.m. ET) in San Francisco, CA.
加州南旧金山，2025年1月8日 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.（纳斯达克：RIGL）是一家专注于血液疾病和癌症的商业阶段生物技术公司，今天宣布，公司总统兼首席执行官Raul Rodriguez将于2025年1月16日（星期四）上午8:15（太平洋时间，11:15 东部时间）在加利福尼亚州旧金山举行的第43届J.P.摩根医疗健康大会上进行公司资料介绍。
To access the live webcast or archived recording, visit the Investor Relations section of the company's website at . Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
要访问直播网络研讨会或存档录音，请访问公司网站的投资者关系部分。在直播网络研讨会开始前请连接到Rigel的网站，以便进行任何软件下载。
About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit .
关于Rigel
Rigel Pharmaceuticals, Inc.（纳斯达克：RIGL）是一家致力于发现、开发和提供显著改善血液疾病和癌症患者生活的新疗法的生物技术公司。Rigel成立于1996年，总部位于加州南旧金山。有关Rigel、公司上市产品以及潜在产品管道的更多信息，请访问。
Contact for Investors & Media:
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
[email protected]
投资者与媒体联系：
投资者：
Rigel Pharmaceuticals, Inc.
650.624.1232
[email protected]
Media:
David Rosen
Argot Partners
646.461.6387
[email protected]
媒体：
大卫·罗森
Argot Partners
646.461.6387
[email protected]
SOURCE Rigel Pharmaceuticals, Inc.
来源：Rigel Pharmaceuticals, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想让贵公司的资讯在PRNEWSWIRE.COM上特色展示吗？
